Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Relmada Therapeutics Inc

RLMD
Current price
3.16 USD -0.04 USD (-1.25%)
Last closed 3.3 USD
ISIN US75955J4022
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 98 971 376 USD
Yield for 12 month +4.29 %
1Y
3Y
5Y
10Y
15Y
RLMD
21.11.2021 - 28.11.2021

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system diseases (CNS) and other disorders in the United States. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a N-methyl-D-aspartate receptor antagonist which is in phase 3 clinical trial for the adjunctive or monotherapy treatment of major depressive disorder. The company is headquartered in Coral Gables, Florida. Address: 2222 Ponce de Leon Boulevard, Coral Gables, FL, United States, 33134

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

12 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures RLMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -161 247 824 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -59.13 %
PEG Ratio
Return On Equity TTM -100.41 %
Wall Street Target Price 12 USD
Revenue TTM
Book Value 2.84 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -2.87 USD
Diluted Eps TTM -2.87 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics RLMD

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History RLMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:4
Payout Ratio
Last Split Date 30.09.2019
Dividend Date 30.09.2019

Stock Valuation RLMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.5431
Price Book MRQ 1.6095

Financials RLMD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators RLMD

For 52 weeks

1.88 USD 7.22 USD
50 Day MA 3.31 USD
Shares Short Prior Month 1 250 653
200 Day MA 3.85 USD
Short Ratio 4.52
Shares Short 1 255 763
Short Percent 4.23 %